Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranolazine in Microvascular Angina (RAMP-ED)
NCT02052011Phase 4Completed
- Sponsor
- Yale University
- Start
- Apr 2014
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ranolazine in microvascular angina (MVA), sponsored by Yale University. Started Apr 2014; status: completed.
02
Drugs
ranolazine
03
Conditions
microvascular angina (MVA)
Beyond the preview
Go deeper on NCT02052011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02052011.